mayo clinic tirzepatide New research from a Clinic–led study suggests that postmenopausal women using menopause hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight and obesity. In Women over 50 lost 35%

A shortage of semaglutide and rising costs have left many people wondering whether a compounded version is a safe way to access this drug

"The doctor said, 'you are having an allergic reaction and you better stop it'," he said

Convenience: With once-weekly injections, these medications fit seamlessly into busy lifestyles

Because Ozempic slows down the exit door of your stomach, any oral medication you swallowincluding doxycyclinewill sit in your stomach for a longer period before moving into the small intestine where it is mostly absorbed

This dual actionbiological satiety plus reduced craving intensityaddresses both physical and psychological drivers of weight gain

Their outcomes further overlap to include cardiovascular and hepatic benefits [17, 18]